한국어 / ENG

Core Technology

Olive Healthcare Core Technology
Near-infrared biomarker measurement technology


Reference technology application (450 SCI papers, 39 breast cancer papers)


* Near Infrared (NIR) Technology

NIR refers to an electromagnetic wavelength corresponding to about 780 to 2500 nm.
NIR tissue measurements have been used to measure tissue chromophores to explain the health status of humans so far, e.g., pulse oximeter.
Our real-time tissue measurements are made quantitatively in spectral regions of about 650 to 1100 nm. Our devices use the light source of 8-wavelength NIR LED (Light Emitting Diodes) to calculate oxy-hemoglobin, deoxyhemoglobin, water, and lipid by measuring tissue absorption and scattering during photon migrations.
Directly Conducted Clinical Studies
 
Yonsei Univ. Severance Hospital
Efficacy and safety of assistive diagnostic device
using DMW-NIRS1) in patients with breast masses
  • Sensitivity 97.3% | Specificity 95.7% | AUC 0.99 2)
  • 62 patients w/ lesion(# of Malignant 37 / Benign 25)
  • Early diagnosis of minimum 7mm malignant
  • Sensitive to HER-2 positive & estrogen negative
  • 1) Discrete Multi-Wavelength Near-Infrared Spectroscopy
    2) These results are part of a newly developed index by Olive Healthcare Inc.



    Core Technology

    Olive Healthcare
    Core Technology
    Near-infrared biomarker
    measurement technology


    Near-infrared biomarker measurement technology​
    Reference technology application
    450 SCI papers, 39 breast cancer papers
    * Near Infrared (NIR) Technology

    NIR refers to an electromagnetic wavelength corresponding to about 780 to 2500 nm.
    NIR tissue measurements have been used to measure tissue chromophores to explain the health status of humans so far, e.g., pulse oximeter.
    Our real-time tissue measurements are made quantitatively in spectral regions of about 650 to 1100 nm. Our devices use the light source of 8-wavelength NIR LED (Light Emitting Diodes) to calculate oxy-hemoglobin, deoxyhemoglobin, water, and lipid by measuring tissue absorption and scattering during photon migrations.
    Directly Conducted
    Clinical Studies
    * DMW-NIRS: Discrete
    Multi-Wavelength Near-Infrared Spectroscopy
     
    Yonsei Univ. Severance Hospital
    Efficacy and safety of assistive diagnostic device using DMW-NIRS1) in patients with breast masses
  • Sensitivity 97.3% | Specificity 95.7% | AUC 0.99 2)
  • 62 patients w/ lesion (# of Malignant 37 / Benign 25)
  • Early diagnosis of minimum 7mm malignant
  • Sensitive to HER-2 positive & estrogen negative
  • 1) Discrete Multi-Wavelength Near-Infrared Spectroscopy
    2) These results are part of a newly developed index by Olive Healthcare Inc.
    TOP
    TOP